Willem Ouwehand, MD, PhD, of the University of Cambridge, Cambridge, UK updates us on developments in clinical hematology at the British Society for Haematology (BSH) 2018 Annual Scientific Meeting, Liverpool, UK. He notes the influx of new compounds and interventions coming into the field, and notes the importance of keeping the cost of these treatments reasonable. He briefly discusses developments in the genome editing of stem cells, and holds promise that this may even be curative for certain rare disorders of blood; for instance, sickle cell disease.
